Hepatitis C: A clinical update

Steven D. Colquhoun

doi:10.1001/archsurg.1996.01430130020004

Hepatitis C: A clinical update

Steven D. Colquhoun

Research output: Contribution to journal › Review article › peer-review

19 Scopus citations

Abstract

Hepatitis C virus is now known to be the causative agent for at least 90% of non-A, non-B hepatitis cases. In the few years since its characterization, much has been learned about this virus and the scope of its disease. It now appears that close to 100% of infections may become chronic, with delayed but potentially devastating consequences. The treatment options for hepatitis C remain limited and less than satisfactory. A vaccine seems to be a distant goal, but other strategies for treatment may be closer. For now, the best option remains prevention.

Original language	English (US)
Pages (from-to)	18-23
Number of pages	6
Journal	Archives of Surgery
Volume	131
Issue number	1
DOIs	https://doi.org/10.1001/archsurg.1996.01430130020004
State	Published - Jan 1996
Externally published	Yes

ASJC Scopus subject areas

Surgery

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/archsurg.1996.01430130020004

Cite this

@article{7f740e0d4a7f4ad396d1117889fcd9c9,

title = "Hepatitis C: A clinical update",

abstract = "Hepatitis C virus is now known to be the causative agent for at least 90% of non-A, non-B hepatitis cases. In the few years since its characterization, much has been learned about this virus and the scope of its disease. It now appears that close to 100% of infections may become chronic, with delayed but potentially devastating consequences. The treatment options for hepatitis C remain limited and less than satisfactory. A vaccine seems to be a distant goal, but other strategies for treatment may be closer. For now, the best option remains prevention.",

author = "Colquhoun, {Steven D.}",

year = "1996",

month = jan,

doi = "10.1001/archsurg.1996.01430130020004",

language = "English (US)",

volume = "131",

pages = "18--23",

journal = "Archives of Surgery",

issn = "0004-0010",

publisher = "American Medical Association",

number = "1",

}

TY - JOUR

T1 - Hepatitis C

T2 - A clinical update

AU - Colquhoun, Steven D.

PY - 1996/1

Y1 - 1996/1

N2 - Hepatitis C virus is now known to be the causative agent for at least 90% of non-A, non-B hepatitis cases. In the few years since its characterization, much has been learned about this virus and the scope of its disease. It now appears that close to 100% of infections may become chronic, with delayed but potentially devastating consequences. The treatment options for hepatitis C remain limited and less than satisfactory. A vaccine seems to be a distant goal, but other strategies for treatment may be closer. For now, the best option remains prevention.

AB - Hepatitis C virus is now known to be the causative agent for at least 90% of non-A, non-B hepatitis cases. In the few years since its characterization, much has been learned about this virus and the scope of its disease. It now appears that close to 100% of infections may become chronic, with delayed but potentially devastating consequences. The treatment options for hepatitis C remain limited and less than satisfactory. A vaccine seems to be a distant goal, but other strategies for treatment may be closer. For now, the best option remains prevention.

UR - http://www.scopus.com/inward/record.url?scp=0030060114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030060114&partnerID=8YFLogxK

U2 - 10.1001/archsurg.1996.01430130020004

DO - 10.1001/archsurg.1996.01430130020004

M3 - Review article

C2 - 8546572

AN - SCOPUS:0030060114

SN - 0004-0010

VL - 131

SP - 18

EP - 23

JO - Archives of Surgery

JF - Archives of Surgery

IS - 1

ER -

Hepatitis C: A clinical update

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this